Biotech

Portfolio

Lists

Sources

Guide

8.0

Axial

9.0

Borlaug’s Substack

8.5

BowTiedBiotech

9.0

Breaking Biotech

9.0

Jonathan Faison

9.0

Matt Gamber’s Biotech Newsletter

9.0

The Century of Biology

8.0

Turning Rough Stones

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 646

April 18, 2025, 4:03 p.m.

Some Paywall

BowTiedBiotech

The Great Biotech Reset | Ep. 645

April 17, 2025, 10:06 p.m.

Some Paywall

BowTiedBiotech

Navigating the Complex Job Market in Biotech & Academia | Ep. 644

April 16, 2025, 9:34 a.m.

Some Paywall

Jonathan Faison

Ascendis Pharma: Rare Disease Player Is A Buy On Yorvipath Launch Trajectory

April 14, 2025, 8:38 p.m.

Paywall

Turning Rough Stones

Bank of Botetourt (BORT): cheap, much cheaper than you would think

April 14, 2025, 6:36 p.m.

No Paywall

Matt Gamber’s Biotech Newsletter

Ideaya is undervalued on their lead asset Darovasertib alone - you get the rest of the pipeline for free.

April 14, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $CRSP | Ep. 642

April 14, 2025, 9:30 a.m.

Some Paywall

BowTiedBiotech

Who Owns the Right to Rewrite DNA? | Ep. 641

April 13, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 640

April 12, 2025, 11:05 a.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 639

April 11, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

Preserving Shrinking Cash Runways | Ep. 638

April 10, 2025, 10:20 p.m.

Some Paywall

BowTiedBiotech

Revolutionizing Healthcare With The Power of Digital Twins | Ep. 637

April 9, 2025, 10:33 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

The Biotech Recession Shopping List

April 7, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $RYTM | Ep. 635

April 6, 2025, 7:05 p.m.

Some Paywall

BowTiedBiotech

The DEI Pendulum in Biotech | Ep. 634

April 6, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 633

April 5, 2025, 11:32 a.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 632

April 4, 2025, 4:03 p.m.

Some Paywall

BowTiedBiotech

Debt > Equity? | Ep. 631

April 3, 2025, 10:33 p.m.

Some Paywall

BowTiedBiotech

Biotech’s Broken Incentive Machine | Ep. 630

April 2, 2025, 10:34 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Free Post: March Performance Update

March 31, 2025, 11:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $VERV | Ep. 628

March 31, 2025, 9:31 a.m.

Some Paywall

BowTiedBiotech

Building Differentiated ADC Programs | Ep. 627

March 30, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 626

March 29, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 625

March 28, 2025, 4:36 p.m.

Some Paywall

BowTiedBiotech

Biotech and the New Reality of VC Fundraising | Ep. 624

March 27, 2025, 10:42 p.m.

Some Paywall

BowTiedBiotech

Biotech Startups Are Overtaking Academia? | Ep. 623

March 26, 2025, 10:33 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Edgewise's Sevasemten program meets the FDA's guidance for Accelerated Approval - and has a good chance of working in Phase 3.

March 24, 2025, 10 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $KYMR | Ep. 621

March 24, 2025, 9:31 a.m.

Some Paywall

BowTiedBiotech

Obesity 2030: Too Big to Buy? | Ep. 620

March 23, 2025, 1:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Update | Ep. 619

March 22, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 618

March 21, 2025, 4:01 p.m.

Some Paywall

BowTiedBiotech

The Global Landscape of Biotech Transactions | Ep. 617

March 20, 2025, 11:14 p.m.

Some Paywall

BowTiedBiotech

Beyond CRISPR | Ep. 616

March 19, 2025, 12:31 p.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

I'm Still Struggling With Celcuity's Upcoming Phase 3 Readout - But It Has A Real Chance

March 17, 2025, 10:03 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $NKTR | Ep. 614

March 17, 2025, 9:30 a.m.

Some Paywall

The Century of Biology

On Modality Commoditization

March 16, 2025, 6:01 p.m.

No Paywall

BowTiedBiotech

The Role of AI in Therapeutic Development | Ep. 613

March 16, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 612

March 15, 2025, 12:31 p.m.

Some Paywall

Borlaug’s Substack

#12: Let Me Do It for You (CRO Primer)

March 14, 2025, 10:16 p.m.

No Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 611

March 14, 2025, 4:12 p.m.

Some Paywall

BowTiedBiotech

Panic Now or Pay Later | Ep. 610

March 13, 2025, 10:24 p.m.

Some Paywall

Jonathan Faison

Arcutis Biotherapeutics: Topical Derm Player Continues To Execute

March 12, 2025, 6:01 p.m.

Paywall

BowTiedBiotech

The Maturation of AI in Drug Discovery | Ep. 609

March 12, 2025, 10:52 a.m.

Some Paywall

Matt Gamber’s Biotech Newsletter

Q4 2024 Earnings Call Recaps, Part 2

March 10, 2025, 10:02 a.m.

No Paywall

BowTiedBiotech

BIOTECH MARKET RESEARCH $IMVT | Ep. 607

March 10, 2025, 9:31 a.m.

Some Paywall

BowTiedBiotech

Biotech Showdown - Venture Capital vs Public Equity | Ep. 606

March 9, 2025, 12:31 p.m.

Some Paywall

BowTiedBiotech

Weekly Biotech News Fix | Ep. 605

March 8, 2025, 4:03 p.m.

Some Paywall

BowTiedBiotech

Sweat Equity - Your Weekly Biotech News Fix | Ep. 604

March 7, 2025, 5:03 p.m.

Some Paywall

BowTiedBiotech

M&A or Bust | Ep. 603

March 7, 2025, 12:11 a.m.

Some Paywall

BowTiedBiotech

History Repeats Itself: Obesity vs. Immune-Oncology | Ep. 603

March 5, 2025, 12:08 p.m.

Some Paywall

1 - 50 of 1475 Results

2 3

No commentary found!

No news content found!

Add to your lists

Recommended Content

Biotech